These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2006-001384-30||Standard vs reduced dose naloxone for the reversal of opiate overdose. Does dose modification increase the likelihood of reaching hospital and entering a substance misuse programme?||not-yet-due|
|Ongoing||2009-016716-20||Better targeting of antidepressants in older people: the influence of age and genetic background on serotonin signalling||not-yet-due|
|Ongoing||2010-023254-36||Is a short course of azithromycin effective in the treatment of mild to moderate pelvic inflammatory disease (PID)?||not-yet-due|
|Ongoing||2011-003530-13||Randomised phase II window study of short-term preoperative treatment with the PI3K inhibitor GDC-0941 plus Anastrozole versus Anastrozole alone in patients with ER-positive primary breast cancer||not-yet-due|
|Not reported||2011-003695-36||Is intravenous iron and darbepoetin more effective than oral iron in reducing blood transfusion requirements for patients undergoing cardiac surgery||2012-08-20||due-trials|
|Ongoing||2011-004078-26||A double blind placebo controlled randomised trial to study the effects of birch pollen specific immunotherapy (BP-SIT) on the symptoms of the oral allergy syndrome in adult patients.||not-yet-due|
|Not reported Terminated||2012-000594-24||An open study to investigate the effects of injection immunotherapy on allergen-specific T and B cell responses in adult patients with seasonal allergic rhinitis.||2012-08-24||due-trials|
|Ongoing||2013-002845-12||An international multicentre open-label comparative therapeutic exploratory trial to investigate the role of a new neonatal formulation of dobutamine in the treatment of haemodynamic insufficiency in ...||not-yet-due|
|Ongoing||2017-004141-24||A phase IV, open-label pilot study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background...||not-yet-due|